Exagen inc. XGN.US AI Analysis
BetaUS StockHealthcare
(No presentation for XGN)
XGN Value Score
3
24
15
Limited Growth
Analysis Conclusion
The stock has a lower value rating; if aiming for value investing, existing long-term positions might require gradual reduction.
XGN Value Strategy Backtest
The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.
Entry
Exit
The Backtest Result of XGN from 2019-09-19 till Now
- -
- Cumulative Return
- -
- Annual Return
- -
- Volatility
- -
- Sharpe Ratio
Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from September, 2019 to June, 2025. (Total Trades: 0)
| XGN | Sector | US Overall Market | |
|---|---|---|---|
| Wining Rate | - | 47% | 55% |
| Avg Return | - | 46.4% | 58.3% |
| Avg Profit | - | 145.8% | 131.3% |
| Avg Loss | - | -40.5% | -31% |
| Avg Risk-Reward Ratio | - | 360% | 423.3% |